Skip to search formSkip to main contentSkip to account menu

RS 8359

Known as: RS-8359 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

NitrilesPyrimidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
RS 8359
1997
1997
The effects of RS‐8359 on cardiovascular function in healthy subjects and depressed patients
The potential liability of RS-8359 for the ‘cheese’ effect that is characteristic of the classical monoamine oxidase inhibitors… 
1997
1997
The pharmacokinetic profile of RS‐8359
RS-8359 is very rapidly absorbed, metabolized and distributed following oral dosing, with significant concentrations of both… 
1997
1997
Pharmacology of the new reversible inhibitor of monoamine oxidase A, RS‐8359
RS-8359 is a new reversible inhibitor of monoamine oxidase A (RIMA). With a selectivity ratio of about 2200 for (ho: A:B enzyme… 
1997
1997
Pharmacokinetics and pharmacodynamics of the new reversible MAO-A inhibitor RS-8359
1994
1994
Effects of RS-8359 on reduced local cerebral glucose utilization in the rat subjected to transient forebrain ischemia.
Changes in local cerebral glucose utilization (LCGU) of the postischemic rat brain were investigated using the rat four-vessel… 
1994
1994
Changes in monoamine levels in mouse brain elicited by forced-swimming stress, and the protective effect of a new monoamine oxidase inhibitor, RS-8359